VanEck Associates’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
30,496
-5,245
-15% -$322K ﹤0.01% 1078
2026
Q1
$2.33M Buy
35,741
+5,151
+17% +$377K ﹤0.01% 962
2025
Q4
$2.46M Sell
30,590
-355
-1% -$28.5K ﹤0.01% 954
2025
Q3
$2.54M Sell
30,945
-1,993
-6% -$173K ﹤0.01% 948
2025
Q2
$3M Sell
32,938
-4,208
-11% -$376K ﹤0.01% 891
2025
Q1
$3.4M Buy
37,146
+2,199
+6% +$192K ﹤0.01% 849
2024
Q4
$2.98M Sell
34,947
-1,516
-4% -$133K ﹤0.01% 876
2024
Q3
$3.27M Buy
36,463
+565
+2% +$47.6K ﹤0.01% 792
2024
Q2
$2.83M Buy
35,898
+1,187
+3% +$97.6K ﹤0.01% 775
2024
Q1
$3.14M Buy
34,711
+1,553
+5% +$142K ﹤0.01% 734
2023
Q4
$2.91M Sell
33,158
-118
-0.4% -$9.83K 0.01% 698
2023
Q3
$2.81M Buy
33,276
+2,117
+7% +$191K 0.01% 656
2023
Q2
$3.08M Buy
31,159
+2,599
+9% +$245K 0.01% 625
2023
Q1
$2.74M Sell
28,560
-401
-1% -$37.1K 0.01% 622
2022
Q4
$2.63M Sell
28,961
-2,826
-9% -$240K 0.01% 611
2022
Q3
$2.52M Buy
31,787
+108
+0.3% +$9.15K 0.01% 594
2022
Q2
$2.64M Sell
31,679
-2,681
-8% -$221K 0.01% 598
2022
Q1
$2.83M Buy
34,360
+192
+0.6% +$15K 0.01% 625
2021
Q4
$2.56M Sell
34,168
-3,752
-10% -$282K 0.01% 645
2021
Q3
$2.87M Sell
37,920
-2,786
-7% -$216K 0.01% 582
2021
Q2
$3.15M Sell
40,706
-1,310
-3% -$101K 0.01% 551
2021
Q1
$2.95M Buy
+42,016
New +$3.17M 0.01% 533
2014
Q3
Sell
-48,150
Closed -$2.23M 714
2014
Q2
$2.23M Buy
48,150
+4,570
+10% +$215K 0.01% 333
2014
Q1
$2.02M Buy
43,580
+9,041
+26% +$395K 0.01% 316
2013
Q4
$1.42M Buy
+34,539
New +$1.36M 0.01% 349

Other funds holding DOX

VanEck Associates's DOX Position: Q2 2026 in Review

VanEck Associates reduced its Amdocs (DOX) stake by 15% in Q2 2026, selling an estimated $322K and leaving 30,496 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

VanEck Associates first reported a position in DOX in Q4 2013 and has held it in 25 quarters since. The position peaked at $3.4M in Q1 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • VanEck Associates held 30,496 shares of Amdocs worth $1.54M as of Q2 2026.
  • VanEck Associates sold 5,245 Amdocs shares in Q2 2026, an estimated $322K.
  • Amdocs made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1078 holding.
  • VanEck Associates first reported a position in Amdocs in Q4 2013 and has held it in 25 quarters since.
  • VanEck Associates's Amdocs position peaked at $3.4M in Q1 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.